141 studies found for:    Open Studies | "Lupus Erythematosus, Systemic"
Show Display Options
Rank Status Study
21 Unknown  International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
22 Not yet recruiting A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Ustekinumab;   Drug: Placebo;   Other: Concomitant Medication
23 Unknown  Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Dehydroepiandrosterone (DHEA)
24 Recruiting EFECTIVENESS OF PHARMACEUTICAL CARE IN THE ADHERENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS TREATMENT
Conditions: Systemic Lupus Erythematosus;   Medication Adherence
Interventions: Other: Pharmaceutical Care;   Other: Control
25 Recruiting A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.
Condition: Systemic Lupus Erythematosus
Interventions: Drug: CC-220;   Drug: Placebo
26 Recruiting Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
27 Unknown  Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)
Conditions: Antiphospholipid Syndrome;   Thrombophilia Due to Antiphospholipid Antibody;   Systemic Lupus Erythematosus
Intervention: Other: Phlebotomy
28 Unknown  Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan
Conditions: Rheumatoid Arthritis;   Systemic Lupus Erythematosus;   Ankylosing Spondylitis
Intervention:
29 Recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab
30 Recruiting BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Belimumab
31 Unknown  Systemic Lupus Erythematosus in Gullah Health
Condition: Systemic Lupus Erythematosus
Intervention:
32 Recruiting Nelfinavir in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Nelfinavir
33 Recruiting Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic Stem Cell Transplantation
34 Unknown  Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease
Condition: Systemic Lupus Erythematosus
Intervention: Drug: quinipril
35 Recruiting Cyclophosphamide and rATG/Rituximab in Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: Hematopoietic stem cell transplantation
36 Not yet recruiting Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous
Condition: Systemic Lupus Erythematous
Intervention: Drug: Treatment by clopidogrel
37 Unknown  Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE)
Conditions: Rheumatoid Arthritis;   Systemic Lupus Erythematosus
Intervention:
38 Unknown  HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Behavioral: Education
39 Unknown  Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Biological: human umbilical cord derived MSC transplantation for SLE
40 Recruiting Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus.
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Cholecalciferol;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years